Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
27.51
+0.53 (1.96%)
May 27, 2025, 2:35 PM - Market open
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.09 billion as of May 27, 2025. Its market cap has decreased by -64.94% in one year.
Market Cap
3.09B
Enterprise Value
2.20B
1-Year Change
-64.94%
Ranking
Category
Stock Price
$27.51
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.09B, an increase of 3,886.63%. That is a compound annual growth rate of 44.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 3.03B | -32.43% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |